These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 15068324)

  • 1. HER-2, EGFR, COX-2 expression status correlated to microvessel density and survival in resected non-small cell lung cancer.
    Brattström D; Wester K; Bergqvist M; Hesselius P; Malmström PU; Nordgren H; Wagenius G; Brodin O
    Acta Oncol; 2004; 43(1):80-6. PubMed ID: 15068324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent co-localization of Cox-2 and laminin-5 gamma2 chain at the invasive front of early-stage lung adenocarcinomas.
    Niki T; Kohno T; Iba S; Moriya Y; Takahashi Y; Saito M; Maeshima A; Yamada T; Matsuno Y; Fukayama M; Yokota J; Hirohashi S
    Am J Pathol; 2002 Mar; 160(3):1129-41. PubMed ID: 11891209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High coexpression of both insulin-like growth factor receptor-1 (IGFR-1) and epidermal growth factor receptor (EGFR) is associated with shorter disease-free survival in resected non-small-cell lung cancer patients.
    Ludovini V; Bellezza G; Pistola L; Bianconi F; Di Carlo L; Sidoni A; Semeraro A; Del Sordo R; Tofanetti FR; Mameli MG; Daddi G; Cavaliere A; Tonato M; Crinò L
    Ann Oncol; 2009 May; 20(5):842-9. PubMed ID: 19153117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HER-2/neu protein expression and gene alteration in stage I-IIIA non-small-cell lung cancer: a study of 140 cases using a combination of high throughput tissue microarray, immunohistochemistry, and fluorescent in situ hybridization.
    Tan D; Deeb G; Wang J; Slocum HK; Winston J; Wiseman S; Beck A; Sait S; Anderson T; Nwogu C; Ramnath N; Loewen G
    Diagn Mol Pathol; 2003 Dec; 12(4):201-11. PubMed ID: 14639106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiological study of HER-2 mutations among EGFR wild-type lung adenocarcinoma patients in China.
    Li X; Zhao C; Su C; Ren S; Chen X; Zhou C
    BMC Cancer; 2016 Oct; 16(1):828. PubMed ID: 27793199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylated epidermal growth factor receptor and cyclooxygenase-2 expression in localized non-small cell lung cancer.
    Kim SJ; Rabbani ZN; Dong F; Vollmer RT; Schreiber EG; Dewhirst MW; Vujaskovic Z; Kelley MJ
    Med Oncol; 2010 Mar; 27(1):91-7. PubMed ID: 19235531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exclusive mutation in epidermal growth factor receptor gene, HER-2, and KRAS, and synchronous methylation of nonsmall cell lung cancer.
    Suzuki M; Shigematsu H; Iizasa T; Hiroshima K; Nakatani Y; Minna JD; Gazdar AF; Fujisawa T
    Cancer; 2006 May; 106(10):2200-7. PubMed ID: 16598760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein overexpression and gene amplification of epidermal growth factor receptor in nonsmall cell lung carcinomas. An immunohistochemical and fluorescence in situ hybridization study.
    Suzuki S; Dobashi Y; Sakurai H; Nishikawa K; Hanawa M; Ooi A
    Cancer; 2005 Mar; 103(6):1265-73. PubMed ID: 15712203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermal growth factor receptor (EGFR) and vascular endothelial growth factor (VEGF) negatively affect overall survival in carcinoma of the cervix treated with radiotherapy.
    Gaffney DK; Haslam D; Tsodikov A; Hammond E; Seaman J; Holden J; Lee RJ; Zempolich K; Dodson M
    Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):922-8. PubMed ID: 12829126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of prognostic implications of HER-2/neu abnormalities in 345 stage I non-small cell carcinomas (NSCLC) and 207 stage I-III neuroendocrine tumours (NET) of the lung.
    Pelosi G; Del Curto B; Dell'Orto P; Pasini F; Veronesi G; Spaggiari L; Maisonneuve P; Iannucci A; Terzi A; Lonardoni A; Viale G
    Int J Cancer; 2005 Jan; 113(1):101-8. PubMed ID: 15386424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer.
    Khuri FR; Wu H; Lee JJ; Kemp BL; Lotan R; Lippman SM; Feng L; Hong WK; Xu XC
    Clin Cancer Res; 2001 Apr; 7(4):861-7. PubMed ID: 11309334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorylation, but not overexpression, of epidermal growth factor receptor is associated with poor prognosis of non-small cell lung cancer patients.
    Kanematsu T; Yano S; Uehara H; Bando Y; Sone S
    Oncol Res; 2003; 13(5):289-98. PubMed ID: 12688680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of cyclooxygenase-1 and cyclooxygenase-2 in bronchial epithelium and nonsmall cell lung carcinoma.
    Hastürk S; Kemp B; Kalapurakal SK; Kurie JM; Hong WK; Lee JS
    Cancer; 2002 Feb; 94(4):1023-31. PubMed ID: 11920472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between cyclooxygenase-2 and tumor angiogenesis in non-small cell lung cancer.
    Kim HS; Youm HR; Lee JS; Min KW; Chung JH; Park CS
    Lung Cancer; 2003 Nov; 42(2):163-70. PubMed ID: 14568683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclooxygenase-2 protein levels are independent of epidermal growth factor receptor expression or activation in operable non-small cell lung cancer.
    Richardson CM; Richardson D; Swinson DE; Swain WA; Cox G; O'Byrne KJ
    Lung Cancer; 2005 Apr; 48(1):47-57. PubMed ID: 15777970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermal Growth Factor Receptor Gene Amplification Predicts Worse Outcome in Patients With Surgically Resected Nonadenocarcinoma Lung Cancer.
    Chang H; Yang Y; Lee JS; Jheon SH; Kim YJ; Chung JH
    Clin Lung Cancer; 2019 Jan; 20(1):7-12.e1. PubMed ID: 30017644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous expression of c-erbB-1, c-erbB-2, c-erbB-3 and c-erbB-4 receptors in non-small-cell lung carcinomas: correlation with clinical outcome.
    Koutsopoulos AV; Mavroudis D; Dambaki KI; Souglakos J; Tzortzaki EG; Drositis J; Delides GS; Georgoulias V; Stathopoulos EN
    Lung Cancer; 2007 Aug; 57(2):193-200. PubMed ID: 17442448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of COX-2 in stomach cancers and its relation to their biological features.
    Han SL; Tang HJ; Hua YW; Ji SQ; Lin DX
    Dig Surg; 2003; 20(2):107-14. PubMed ID: 12686777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic effect of single and multiple cancer-related somatic mutations in resected non-small-cell lung cancer.
    Jao K; Tomasini P; Kamel-Reid S; Korpanty GJ; Mascaux C; Sakashita S; Labbé C; Leighl NB; Liu G; Feld R; Bradbury PA; Hwang DM; Pintilie M; Tsao MS; Shepherd FA
    Lung Cancer; 2018 Sep; 123():22-29. PubMed ID: 30089591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of p63, TTF-1 and Maspin in Non-Small Cell Lung Carcinoma and Their Effect on the Prognosis and Differential Diagnosis.
    Yaman B; Nart D; Ekren PK; Çok G; Veral A
    Turk Patoloji Derg; 2015; 31(3):163-74. PubMed ID: 26456962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.